MedWatch

Novo Nordisk suspends Twitter advertising

The pharmaceutical firm is joining the stream of companies halting paid advertising on the social media platform after it was taken over by Tesla billionaire Elon Musk.

Photo: Dado Ruvic/REUTERS / X02714

Novo Nordisk has told industry media Endpoints that it is pausing its Twitter advertising due to controversies surrounding the platform since Elon Musk took it over.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Bank believes in cancer approval for Genmab

In Jyske Bank’s eyes, Genmab’s newest cancer candidate is almost certain to be approved, though the bank says stock increases in the past year have reduced the upside potential for the Danish biotech firm.

Further reading

Related articles

Latest news

See all jobs